isoxazoles has been researched along with panobinostat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bandolik, JJ; Hamacher, A; Hansen, FK; Kassack, MU; Kurz, T; Rodrigues Moita, AJ | 1 |
1 other study(ies) available for isoxazoles and panobinostat
Article | Year |
---|---|
Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Ovarian Neoplasms; Panobinostat; Pyridones; Pyrimidines; Resorcinols | 2020 |